This report focuses on the global Pharmaceutical CDMO Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical CDMO Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The Europe pharmaceutical contract development and manufacturing organization (CDMO) market is estimated to garner a revenue of USD 39920.2 Million by the end of 2030, by growing at a CAGR of 6.7% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market in the region generated a revenue of USD 21133.3 Million. The growth of the market can be attributed primarily to the growing prevalence of different types of chronic diseases in the region, such as cancer, diabetes, and cardiovascular diseases amongst others, and therefore the need for advanced pharmaceutical drugs that can help in the treatment of these deadly diseases.
The global Active Pharmaceutical Ingredient market size reached a staggering USD 216.5 billion in 2024. This impressive figure highlights the significant role APIs play in developing and manufacturing the medications we rely on. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 7.22%, reaching an estimated USD 306.90 billion by 2029.
Global veterinary cro and cdmo market size is expected to reach $9.87 Bn by 2028 at a rate of 8.9%, segmented as by service type, discovery, development, manufacturing, packaging and labeling, market approval and post-marketing
According to the Market Statsville Group (MSG), the Global Biopharmaceutical CDMO Service Market size is expected to grow from USD 100.4 billion in 2023 to USD 192.2 billion by 2033, at a CAGR of 6.7% from 2023 to 2033.
Due to the increasing elderly population, growing demand for medicines, rising investment in healthcare, and the constant introduction of new products, the global biologics CDMO market was valued at $13,173.7 million in 2021. This is expected to reach $31,839.7 million by 2030, at a CAGR of 10.3% from 2021 to 2030. With the rise in the cases of infections among people, pharma companies are engaging in partnerships with CDMOs for meeting the demand for antibiotics.
This study offers a comprehensive, 360 degree analysis on the Temperature Controlled Pharmaceutical Containers market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Temperature Controlled Pharmaceutical Containers market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Pharmaceutical logistics is a specific branch of logistics services in which service providers are focused on providing storage, transporting, proper handling and delivering the pharmaceutical products from the manufacturing location to the desired location. Pharmaceutical logistics need the services to be selected as per the regulations of products provided by the authorities.
PharmaTech LLC is committed to delivering high-quality and superior generic Rx & OTC pharmaceutical products. It is a leading & reputed platform and a contract development & manufacturing organization (CDMO) offering full-service and specializing in top-notch pharmaceuticals products development, contract testing & manufacturing services.
Some key players in the Saudi Arabia pharmaceutical market covered in this report are SPIMACO, Tabuk Pharmaceuticals Manufacturing Co., Juphar, Jamjoom Pharma, GlaxoSmithKline plc. Pfizer Inc., Novartis AG and Sanofi.
Future Market Insights has profiled a few of the companies that have shaped the pharmaceutical filtration market. These include 3M Companies, Amazon Filters, Eaton Corporation Plc. GE Healthcare Inc., Merck KGaA, Pall Corporation, Parker Hannifin Corporation, Meissner Filtration Products, Sartorius Stedim Biotech, and The Marmon Group LLC.
Global pharmaceutical logistics market is expected to rise to an estimated value of USD 98.19 billion by 2026, registering a steady CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the growing demand for more effective and efficient logistics service amid a rise in consumption of pharmaceutical products.
According to the revised report published by Persistence Market Research, the global active pharmaceutical ingredient market valued at around US$ 180 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021–2031).
Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026.
Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the constrained budgets and the need for reducing the R&D expenses as well as manufacturing costs.
Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the constrained budgets and the need for reducing the R&D expenses as well as manufacturing costs.
Pharmaceutical logistics is a specific branch of logistics services in which service providers are focused on providing storage, transporting, proper handling and delivering the pharmaceutical products from the manufacturing location to the desired location. Pharmaceutical logistics need the services to be selected as per the regulations of products provided by the authorities.
According to the revised report published by Persistence Market Research, the global active pharmaceutical ingredient market valued at around US$ 180 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021–2031).
Global sales of pharmaceutical intermediates closed in on US$ 26 billion 2018, which is likely to see modest Y-o-Y growth in 2019, by an estimated 3.6% rate. More than 70% of the pharmaceutical intermediates consumed.
Global pharmaceutical logistics market is expected to rise to an estimated value of USD 98.19 billion by 2026, registering a steady CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the growing demand for more effective and efficient logistics service amid a rise in consumption of pharmaceutical products.
The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031). Get Free Request Sample Report @ https://straitsresearch.com/report/nucleic-acid-therapeutics-cdmo-market/request-sample
The global nucleic acid therapeutics CDMO market is expected to reach $4,463.7 Million by 2030, with a CAGR of 11.09 % during the forecast period 2021-2030.
The Active Pharmaceutical Ingredient Industry is driven by the continuous research and development of novel drugs, the rising prevalence of chronic diseases, and the increasing demand for affordable medications. According to a report by Ken Research, the global Active Pharmaceutical Ingredient Market Size is expected to reach a staggering $342.9 billion by 2030.
Owing to immense pressure on biotech companies to decrease the turnaround time, increase cost effectiveness, India is increasingly becoming a suitable place for carrying out clinical trials owing to its large human resource and technical expertise. Visit Now https://www.foodresearchlab.com/blog/india-popular-destination-for-clinical-trials/ For Enquiry United Kingdom: +44 – 161 818 4656 India: +91 9566299022 info@foodresearchlab.com
The global peptide synthesis market is estimated to grow majorly on account of the increasing demand for personalized medicine and the adoption of precision medicine.
The complexities of drug development and the strict regulatory requirements set forth by the USFDA pose significant challenges for pharmaceutical companies. Their primary goal remains to quickly bring innovative treatments to patients while adhering to the USFDA’s stringent standards, ensuring patient safety and product efficacy.
The latest report by Precision Business Insights, titled “Peptide Synthesis Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.
Services including packaging and labeling, clinical supplies logistics & distribution, comparator sourcing, and clinical supplies management are all part of the clinical trial supplies (CTS) market.
According to the latest research report by IMARC Group, The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028. More Info:- https://www.imarcgroup.com/formulation-development-outsourcing-market
The report "Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027", is expected to reach USD 5.4 billion by 2027 from an estimated USD 2.9 billion in 2022 at a CAGR of 13.3%.
The global contract development manufacturing organizations market size is expected to grow from $176.19 billion in 2021 to $195.59 billion in 2022 at a compound annual growth rate (CAGR) of 11%.
The pharmaceutical sector is an ever-evolving space. In such a dynamic industry, validation from reputed bodies can dramatically influence a company’s standing in global markets.
The pharmaceutical sector is an ever-evolving space. In such a dynamic industry, validation from reputed bodies can dramatically influence a company’s standing in global markets.
According to #TechSci Research report, Cell & Gene Therapy Cold Chain Logistics Market stood at USD1316.93 million in 2021 and is expected to grow at a CAGR of 14.29% by 2027. Gain More Insight: https://bit.ly/3IWQmb0 Get Sample Report: https://bit.ly/3LtYC3L Press Release: https://bit.ly/3DFYpIl Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
MarketReportsOnline.com adds " Global Healthcare CMO Market: Trends & Opportunities (2015-2020)" report to its research store. http://www.marketreportsonline.com/443804.html.
Being a leader in manufacturing national comparables, PharmaTech LLC is spread across a manufacturing space within the area of 75,000 square feet. It continues to implement improvements within their processes to meet the customers’ expectations and benefit them, while concerning the heath of their customers.
Pharmatech LLC is an integrated Contract Development and Manufacturing Organization (CDMO) offering one-stop solutions in the development of both Rx and OTC products. Pharmatech LLC is a FDA-registered and DEA-Licensed, inspected and approved Company that develops both Rx and OTC products with the highest standards and current good manufacturing practices. Pharmatech LLC provides turnkey research and formulation development services for solid, liquid, and topical Rx, OTC and supplement product to its clients worldwide.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
Aarti Pharmalabs Ltd specializes in the clinical phase and commercial production of APIs and NCEs, intermediates, regulatory starting materials, key building blocks and xanthine derivatives. Our offerings include process R&D, analytical method development and validations, stability studies, scale-up and process optimization, process validations and commercial production. The quality and purity of our products have enabled us to be the leading Active Pharmaceutical ingredients manufacturers in India.
Contract Research Organization employ a highly skilled workforce of scientists, clinicians, and other professionals who have the expertise and experience needed to conduct complex research studies.
Dapagliflozin, an effective medication for adults with Type 2 diabetes, works by inhibiting kidney glucose reabsorption and lowering blood sugar levels. It enables the elimination of excess glucose through urine. Moreover, it plays a vital role in mitigating the risk of heart failure in individuals with Type 2 diabetes who have underlying heart and blood vessel conditions or multiple risk factors.
PharmaTech LLC is an FDA-registered & DEA-Licensed, inspected and approved organization, offers one-stop solutions in developing & manufacturing both Rx and OTC products as per the Current Good Manufacturing Practices.
Pharmatech LLC is a FDA-registered and DEA-Licensed, inspected and approved Contract Development & Manufacturing Organization. They offers one-stop solutions for developing and manufacturing various products including Rx and OTC according to Current Good Manufacturing Practices.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.